BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26840262)

  • 1. PHOX2B is a suppressor of neuroblastoma metastasis.
    Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
    Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
    Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
    Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung-residing metastatic and dormant neuroblastoma cells.
    Edry Botzer L; Maman S; Sagi-Assif O; Meshel T; Nevo I; Bäuerle T; Yron I; Witz IP
    Am J Pathol; 2011 Jul; 179(1):524-36. PubMed ID: 21703429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
    Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
    Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of β-catenin and paired-like homeobox 2B (PHOX2B) expression in neuroblastoma patients; predictive and prognostic value.
    El-Shazly SS; Hassan NM; Abdellateif MS; El Taweel MA; Abd-Elwahab N; Ebeid EN
    Exp Mol Pathol; 2019 Oct; 110():104272. PubMed ID: 31220430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.
    Grèze V; Brugnon F; Chambon F; Halle P; Canis M; Amiot C; Grémeau AS; Pereira B; Yáñez Peralta Y; Tchirkov A; Kanold J
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27734578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
    Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
    J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
    de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
    Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.
    Yue Z; Gao C; Xing T; Zhao W; Duan C; Wang X; Jin M; Su Y
    Pediatr Blood Cancer; 2023 May; 70(5):e30261. PubMed ID: 36815592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
    van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
    Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma.
    Cheung IY; Feng Y; Gerald W; Cheung NK
    Clin Cancer Res; 2008 Nov; 14(21):7020-7. PubMed ID: 18980998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma.
    Wang W; Zhong Q; Teng L; Bhatnagar N; Sharma B; Zhang X; Luther W; Haynes LP; Burgoyne RD; Vidal M; Volchenboum S; Hill DE; George RE
    Oncogene; 2014 Jun; 33(25):3316-24. PubMed ID: 23873030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
    Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
    Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
    Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
    Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma.
    Fan H; Xing T; Hong H; Duan C; Zhao W; Zhao Q; Wang X; Huang C; Zhu S; Jin M; Su Y; Gao C; Ma X
    Pediatr Hematol Oncol; 2022 May; 39(4):343-356. PubMed ID: 34752187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Phox2B homeobox gene is mutated in sporadic neuroblastomas.
    van Limpt V; Schramm A; van Lakeman A; Sluis P; Chan A; van Noesel M; Baas F; Caron H; Eggert A; Versteeg R
    Oncogene; 2004 Dec; 23(57):9280-8. PubMed ID: 15516980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
    Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
    Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
    Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
    Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
    Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.